87 related articles for article (PubMed ID: 5749047)
1. [Urolithiasis during treatment of carbonic anhydrase inhibitors].
Kondo T; Sakaue E; Koyama S; Matsuo M; Takahashi Y
Nihon Ganka Kiyo; 1968 Apr; 19(4):576-84. PubMed ID: 5749047
[No Abstract] [Full Text] [Related]
2. Basic studies on the cause of urolithiasis. 3. Role of urinary citrate in urolithiasis.
Matsuo M
Hinyokika Kiyo; 1966 Sep; 12(9):869-80 concl. PubMed ID: 6009217
[No Abstract] [Full Text] [Related]
3. The effect of carbonic anhydrase inhibitors on urinary calcium and citrate.
Reeder J; Wallace MR
Trans Ophthalmol Soc N Z; 1979; 31():51-2. PubMed ID: 293084
[No Abstract] [Full Text] [Related]
4. Acetazolamide and sodium bicarbonate induced nephrocalcinosis and nephrolithiasis; relationship to citrate and calcium excretion.
Parfitt AM
Arch Intern Med; 1969 Dec; 124(6):736-40. PubMed ID: 5353483
[No Abstract] [Full Text] [Related]
5. Urinary calculi with methazolamide therapy.
Ellis PP
Doc Ophthalmol; 1973 Feb; 34(1):137-42. PubMed ID: 4706085
[No Abstract] [Full Text] [Related]
6. Effect of antiepileptic drug polytherapy on crystalluria.
Go T
Pediatr Neurol; 2005 Feb; 32(2):113-5. PubMed ID: 15664771
[TBL] [Abstract][Full Text] [Related]
7. [Urolithiasis and Itsenko-Cushing disease (A clinico-roentgeno-laboratory study)].
Kuuz AL; Bukhman AI
Probl Endokrinol (Mosk); 1968; 14(6):14-9. PubMed ID: 5734445
[No Abstract] [Full Text] [Related]
8. [Clinical strategies for prevention of drug-induced urinary calculi].
Kohjimoto Y; Sasaki Y; Hara I
Clin Calcium; 2011 Oct; 21(10):1457-63. PubMed ID: 21960230
[TBL] [Abstract][Full Text] [Related]
9. [Urine saturation with calcium oxalate in urolithiasis].
Bogado CE; Zanchetta JR
Medicina (B Aires); 1988; 48(1):39-44. PubMed ID: 3216787
[No Abstract] [Full Text] [Related]
10. Promoters and inhibitors of calcium urolithiasis in children.
Lama G; Carbone MG; Marrone N; Russo P; Spagnuolo G
Child Nephrol Urol; 1990; 10(2):81-4. PubMed ID: 2253256
[TBL] [Abstract][Full Text] [Related]
11. [Carbonic anhydrase inhibitors and calcium phosphate stones].
Barbey F; Nseir G; Ferrier C; Burnier M; Daudon M
Nephrologie; 2004; 25(5):169-72. PubMed ID: 15455790
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of risk index according to Tiselius in patients with calcium urinary stones].
Głuszek J; Raszeja-Wanic B; Boruczkowska A; Musialik D
Pol Tyg Lek; 1989 Feb; 44(9):223-5. PubMed ID: 2813184
[TBL] [Abstract][Full Text] [Related]
13. Analysis of calcium, oxalate, and citrate interaction in idiopathic calcium urolithiasis in children.
Milosević D; Batinić D; Konjevoda P; Blau N; Stambuk N; Nizić L; Vrljicak K; Batinić D
J Chem Inf Comput Sci; 2003; 43(6):1844-7. PubMed ID: 14632431
[TBL] [Abstract][Full Text] [Related]
14. Decreased libido--a side effect of carbonic anhydrase inhibitor.
Wallace TR; Fraunfelder FT; Petursson GJ; Epstein DL
Ann Ophthalmol; 1979 Oct; 11(10):1563-6. PubMed ID: 555849
[TBL] [Abstract][Full Text] [Related]
15. The effect of carbonic anhydrase inhibitors on urinary excretion of citrate by humans.
CONSTANT MA; BECKER B
Am J Ophthalmol; 1960 May; 49():929-34. PubMed ID: 13811601
[No Abstract] [Full Text] [Related]
16. [Urinary citrate excretion in children with calcium urolithiasis].
Sikora P; Bieniaś B; Majewski M; Borzecka H; Wawrzyszuk M; Zajaczkowska M
Przegl Lek; 2006; 63 Suppl 3():134-6. PubMed ID: 16898511
[TBL] [Abstract][Full Text] [Related]
17. Changes in urinary composition of calcium oxalate stone formers.
Rahman B; Rahman MA
Biomed Pharmacother; 1986; 40(3):108-10. PubMed ID: 3742009
[TBL] [Abstract][Full Text] [Related]
18. [Citric acid and its significance in urolithiasis].
Gaca A
Z Urol Nephrol; 1967 Mar; 60(3):149-54. PubMed ID: 5626288
[No Abstract] [Full Text] [Related]
19. [Prophylaxis for acetazolamide-induced urolithiasis: clinical study (author's transl)].
Takemoto M
Nihon Hinyokika Gakkai Zasshi; 1978 Aug; 69(8):968-87. PubMed ID: 713211
[No Abstract] [Full Text] [Related]
20. [Studies of citrate metabolism in urolithiasis. 2--Influences of citrate compound administration on sequential excretion of urinary citrate and other substances related to stone formation in healthy controls].
Yasukawa S; Uehara M; Morimoto S; Yoshida T; Fukatani T; Ebisuno S; Ohkawa T
Nihon Hinyokika Gakkai Zasshi; 1987 Apr; 78(4):626-33. PubMed ID: 3669471
[No Abstract] [Full Text] [Related]
[Next] [New Search]
